![]() TRACON Pharmaceuticals TRACON Pharmaceuticals is a biopharmaceutical company focused on developing targeted therapies for cancer and macular degeneration. | Carna Biosciences Carna Biosciences (カルナバイオサイエンス株式会社) is a clinical-stage biopharmaceutical company that develops small molecule drugs and provides drug discovery services. | ||
Founding Date | Founding Date 1994 | Founding Date 2006 | Founding Date 2003 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Alameda, US HQ | Locations San Diego, US HQ | Locations Kobe, JP HQ Natick, US |
Employees | Employees 1,14712% decrease | Employees 268% increase | Employees 65 |
Valuation ($) | Valuation ($) 8.2 b | Valuation ($) 279.4 k | Valuation ($) 38.4 m |
Financial | |||
Revenue (est.) | Revenue (est.) $2.3b (FY, 2025) | Revenue (est.) $12m (FY, 2023) | Revenue (est.) ¥579.1m (FY, 2025) |
Cost of goods | Cost of goods $83.7m (FY, 2025) | Cost of goods N/A | Cost of goods ¥190.9m (FY, 2025) |
Gross profit | Gross profit $2.2b (FY, 2025) | Gross profit N/A | Gross profit ¥388.1m (FY, 2025) |
Net income | Net income $782.6m (FY, 2025) | Net income ($3.6m) (FY, 2023) | Net income (¥2.2b) (FY, 2025) |

TRACON Pharmaceuticals is a biopharmaceutical company focused on developing targeted therapies for cancer and macular degeneration.
View companyCarna Biosciences (カルナバイオサイエンス株式会社) is a clinical-stage biopharmaceutical company that develops small molecule drugs and provides drug discovery services.
View company